Skip to content
Rubyfill Logo
  • Meet RUBY-FILL®
  • Contact

The future of imaging is RUBY

Shaping Tomorrow: The PET Revolution.

Transforming cardiac care with precision, speed, and confidence.

Learn More

WHY PET BELONGS IN EVERY PRACTICE

Better care. 

Better outcomes.
Reduced costs.

Healthcare reform focuses on three goals:1

  1. Better care for individuals
  2. Better health for populations
  3. Reduced costs

Cardiac care remains at the forefront:2

  • Heart disease is the leading cause of death worldwide
  • Claims more lives each year than all cancers combined
  • Despite a 40% decline in deaths over the last decade, the toll remains high

The Challenge

Deliver the right test for the right patient at the right time.

The Solution

Noninvasive cardiac PET imaging meets essential goals for optimal imaging in appropriate patients.

Explore Ruby

Why PET Has Replaced SPECT

PET is the future

For decades, SPECT has crafted a baseline of care, but PET has advanced the industry in every critical measure: speed, precision, and safety.

Rubyfill Machine with screen display

Accuracy and Confidence

  • PET offers the highest diagnostic accuracy, confirmed by evidence reviews3, 4
  • High spatial and contrast resolution with photon attenuation-free images for high sensitivity and specificity4
  • PET provides clear, artifact-free imaging, essential for confidence in diagnosis
  • PET identifies very low-risk patients, eliminating unnecessary tests and enabling timely referrals5

Shorter Acquisition Times

  • PET acquisition time: ~30 minutes6
  • SPECT acquisition time: 3–5 hours6

How We Protect Patients and Staff

  • PET dramatically reduces radiation exposure:5, 7, 8
    • PET: ~1 mSv
    • SPECT: 10–20 mSv
  • Studies confirm PET MPI significantly lowers radiation risk compared to SPECT

Strong Prognostic Power

  • PET identifies risk levels and adds incremental prognostic value9
  • Vasodilator stress PET improves survival prediction beyond clinical variables10
  • Left ventricular ejection fraction reserve adds independent predictive power10
  • PET can be an appropriate initial test for high-risk patients9
  • Adding CFR estimates reclassifies patients across risk levels:11
    • Correctly reclassified 34.8% of intermediate-risk patients15
    • Net reclassification improvement: 0.487 (95% CI: 0.262–0.731)

Advanced Imaging

Compared to SPECT, PET offers:11

  • Advanced PET camera technology (3D, PET/CT, Digital)11
  • Image quality unaffected by body shape or size5
  • Diagnostic clarity in complex multivessel CAD3
  • Attenuation correction reduces artifacts and false positives3,17

Case Study

PET changes the diagnosis

An eighty-year-old woman with hypertension and dyslipidemia presented with chest pain.

Patient

80-year-old female with hypertension and dyslipidemia

Initial SPECT MPI

Mild ischemia reported

Diagnosis

Cardiac catheterization confirmed left main disease and LAD stenosis (80%)

Surgery

Patient underwent CABG surgery

PET MPI

Severe ischemia reported

SPECT Glowing letters

EVIDENCE THAT PET DELIVERS

Proven accuracy.
Proven impact.

PACIFIC Trial Highlights:14

  • Prospective study of 208 patients with stable chest pain and suspected CAD
  • PET demonstrated the highest diagnostic accuracy compared to CCTA and SPECT

Sub-analysis on FFR:5

  • PET assesses microvasculature, unlike CT or CT-FFR
  • Outperformed FFR, CTA, and SPECT in diagnostic performance

Acute Chest Pain Outcomes:

  • Retrospective study of 21,242 ED visits16
  • PET MPI availability led to:
  • Shorter ED stays16
  • 40% less downstream testing compared to SPECT16

EXPERT ENDORSEMENT

Meeting quality goals for imaging

PET MPI delivers:

Cursor icon

Effective

High diagnostic accuracy

Shield with biohazard icon

Safe

Lower radiation exposure

Clock icon

Efficient

5-minute acquisition times

Person with check mark icon

Patient-Centered

Ideal for critically ill, obese, or high-risk patients

Multiple images with gradient colors of orange, purple, blue, pink and teal.

Statement on High Level Radiation

Read More

The path forward starts here

Join us in transforming diagnostic imaging for clinicians 
and patients alike.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Home
  • Meet RUBY-FILL®
  • Contact Us
  • Privacy
  • Terms
  • Opt-out
Rubyfill Rubidium Rb82 Generator Icon in red and blue

REFERENCES

  1. Berwick DM. Launching accountable care organizations–the proposed rule for the Medicare Shared Savings Program. N Engl J Med.2011;364(16):e32.
  2. American Heart Association website. Heart Disease and Stroke Statistics – At-a-Glance. Accessed February 4, 2022. https://www.heart.org/idc/groups/ahamah-public/@wcm/@sop/@smd/documents/downloadable/ucm_470704.pdf
  3. Ghotbi AA, Kjaer A, Hasbak P. Review: comparison of PET rubidium-82 with conventional SPECT myocardial perfusion imaging. Clin Physiol Funct Imaging. 2014;34(3):163-170.
  4. Schindler TH, Bateman TM, Berman DS, et al. Appropriate use criteria for PET myocardial perfusion imaging. J Nucl Med. 2020;61(8):1221-1265.
  5. Bateman TM, Dilsizian V, Beanlands RS, DePuey EG, Heller GV, Wolinsky DA. American society of nuclear cardiology and society of nuclear medicine and molecular imaging joint position statement on the clinical indications for myocardial perfusion PET. J Nucl Cardiol. 2016;23(5): 1227-1231.
  6. Bateman, TM. Advantages and disadvantages of PET and SPECT in a busy clinical practice. J Nucl Cardiol. 2012;19(1):S3-11.
  7. Sanghani abstract. Abstracts of Original Contributions ASNC 2020. J Nucl Cardiol. Published online: September 4, 2020.
  8. Hunter C, Hill J, Ziadi MC, Beanlands RS, deKemp RA. Biodistribution and radiation dosimetry of (82)Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2015;42(7):1032-1042.
  9. Murthy VL, Bateman TM, Beanlands RS, et al. Clinical quantification of myocardial blood flow using PET: joint position paper of the SNMMI cardiovascular council and the ASNC. J Nucl Med. 2018;59(2):273-293.
  10. Dorbala S, Hachamovitch R, Curillova Z, et al. Incremental prognostic value of gated Rb82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging. 2009;2(7):846-854.
  11. Renaud JM, Mylonas I, McArdle B, et al. Clinical interpretation standards and quality assurance for the multicenter PET/CT trial rubidium-ARMI. J Nucl Med. 2014;55(1):58-64.
  12. Murthy VL, Naya M, Foster CR, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124(20):2215-2224.
  13. Yang J, Sohn J, Behr S, Gullberg G, Seo Y. CT-less direct correction of attenuation and scatter in the image space using deep learning for wholebody FDG PET: Potential benefits and pitfalls. Radiology: Artificial Intelligence. 2021;3(2):1-12.
  14. Danad I, Raijmakers PG, Driessen RS, et al. Comparison of coronary CT angiography, SPECT, PET, and hybrid imaging for diagnosis of ischemic heart disease determined by fractional flow reserve. JAMA Cardiol. 2017;2(10):1100-1107.
  15. Driessen RS, Danad I, Stuijfzand WJ, et al. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. J Am Coll Cardiol. 2019;73(2):161-173.
  16. Shaukat Ali A, Finnerty V, Harel F, Marquis-Gravel G, Vadeboncoeur A, Pelletier-Galarneau M. Impact of rubidium imaging availability on management of patients with acute chest pain. [published online ahead of print 2022 Feb 23]. J Nucl Cardiol. 2022;1-10.

© 2026 RUBY. All rights reserved.

Warning: High Level Radiation Exposure with use of incorrect eluent and failure to follow quality control testing Procedure
Please see full prescribing information for complete boxed warning.

High Level Radiation Exposure with Use of Incorrect Eluent
Using the incorrect eluent can cause high Strontium (Sr 82) and (Sr 85) breakthrough levels (5.1)

  • Use only additive-free 0.9% Sodium Chloride Injection USP to elute the generator (2.5)
  • Immediately stop the patient infusion and discontinue the use of the affected RUBY-Full® generator if the incorrect solution is used to elute the generator (4)
  • Evaluate the patient's radiation absorded dose and monitor for the effects of radiation to critical organs such as bone marrow (2.9)

Excess Radiation Exposure with Failure to Follow the Quality Control Testing Procedure
Excess radiation exposure occurs when the levels of Sr 82 or Sr 85 in the Rubidium Rb 82 Chloride injection exceed specific limits (5.2)

  • Strictly adhere to the generator quality control testing procedure (2.6)
  • Stop using the generator if it reaches any of its Expiration Limit (2.7)
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}